Evolent Health, Inc. (EVH)
NYSE: EVH · IEX Real-Time Price · USD
19.69
-0.44 (-2.19%)
At close: Jul 19, 2024, 4:00 PM
11.10
-8.59 (-43.62%)
After-hours: Jul 20, 2024, 1:23 PM EDT

Company Description

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

The company provides platform for health plan administration and value-based business infrastructure.

It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent Health, Inc.
Evolent Health logo
Country United States
Founded 2011
IPO Date Jun 5, 2015
Industry Health Information Services
Sector Healthcare
Employees 4,700
CEO Seth Barrie Blackley

Contact Details

Address:
800 North Glebe Rd, Suite 500
Arlington, Virginia 22203
United States
Phone 571-389-6000
Website evolenthealth.com

Stock Details

Ticker Symbol EVH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001628908
CUSIP Number 30050B101
ISIN Number US30050B1017
Employer ID 32-0454912
SIC Code 8741

Key Executives

Name Position
Dan McCarthy Chief Executive Officer of New Century Health and President
Seth Barrie Blackley Co-Founder, Chief Executive Officer and Director
John Paul Johnson Chief Financial Officer
Jonathan David Weinberg J.D. Chief Legal Officer, General Counsel and Secretary
Emily Rafferty Chief Operating Officer
Aammaad Shams Chief Accounting Officer
Robert Cruz Chief Technology Officer
Jessica White Chief Information Officer
Seth R. Frank Vice President of Investor Relations
Kali Beyah Chief People and Brand Officer

Latest SEC Filings

Date Type Title
Jul 10, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jun 17, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jun 11, 2024 8-K Current Report
Jun 4, 2024 8-K Current Report
May 10, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
Apr 26, 2024 ARS Filing
Apr 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024 DEF 14A Other definitive proxy statements
Apr 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals